Cleared Traditional

K801817 - MICROBIOLOGY CULTURE MEDIA, C.L.E.D. (FDA 510(k) Clearance)

Class I Microbiology device.

K801817 · Radiation Technology, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1980
Decision
27d
Days
Class 1
Risk

K801817 is an FDA 510(k) clearance for the MICROBIOLOGY CULTURE MEDIA, C.L.E.D.. Classified as Culture Media, Non-selective And Differential (product code JSH), Class I - General Controls.

Submitted by Radiation Technology, Inc. (Mchenry, US). The FDA issued a Cleared decision on August 27, 1980 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2320 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Radiation Technology, Inc. devices

Submission Details

510(k) Number K801817 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 31, 1980
Decision Date August 27, 1980
Days to Decision 27 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
75d faster than avg
Panel avg: 102d · This submission: 27d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JSH Culture Media, Non-selective And Differential
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.2320
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.